drugset / Trial / NCT03406689
Comparison of the Efficacy of Nepafenac 0.1% and Nepafenac 0.3 % on Pain Associated With Intravitreal Injections
RandomizedParallel-groupTriple-blindSupportive care
Summary
The analgestic efffect of Nepafenac 0.1% Eye Drops and Nepafenac 0.3% Eye Drops on pain related to intravitreal injections will be evalutated. Pain perception will be assessed by the Short Form of the McGill Pain Questionnaire.
Timeline
- Start
- 2017-09-01
- Primary completion
- 2018-02-28
- Completion
- 2018-03-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Nepafenac | Other / unclassified | 0.1 % | Other |
| Comparator | Nepafenac | Other / unclassified | 0.3 % | Other |
Indications
No indication recorded.